The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

NCT01450813 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia
Neuromuscular Blockade

Interventions

DRUG: Saline 0.06 ml/kg
DRUG: Rocuronium 0.2 mg/kg
DRUG: Rocuronium 0.4 mg/kg
DRUG: Rocuronium 0.6 mg/kg

Sponsor

Medtronic - MITG